$MGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viridian Therapeutics, Inc.\DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Viridian Therapeutics, Inc.\DE. Get notifications about new insider transactions in Viridian Therapeutics, Inc.\DE for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2021 | MGEN | Viridian Therapeut ... | TURNER JOSEPH L | Director | Option Exercise | A | 20.50 | 25,000 | 512,500 | 25,000 | |
Feb 08 2021 | MGEN | Viridian Therapeut ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 20.50 | 25,000 | 512,500 | 25,000 | |
Feb 08 2021 | MGEN | Viridian Therapeut ... | Harwin Peter Evan | Director | Option Exercise | A | 20.50 | 25,000 | 512,500 | 25,000 | |
Feb 08 2021 | MGEN | Viridian Therapeut ... | Kiselak Tomas | Director | Option Exercise | A | 20.50 | 25,000 | 512,500 | 25,000 | |
Feb 08 2021 | MGEN | Viridian Therapeut ... | Morris Arlene | Director | Option Exercise | A | 20.50 | 25,000 | 512,500 | 25,000 | |
Jan 21 2021 | MGEN | Viridian Therapeut ... | Katz Barrett | Chief Medical Offic ... | Option Exercise | A | 23.03 | 356,000 | 8,198,680 | 356,000 | |
Jan 20 2021 | MGEN | Viridian Therapeut ... | Leverone Jason A. | Chief Financial Off ... | Option Exercise | A | 23.03 | 311,785 | 7,180,409 | 311,785 | |
Jan 20 2021 | MGEN | Viridian Therapeut ... | Violin Jonathan | CEO and President | Option Exercise | A | 23.03 | 800,075 | 18,425,727 | 800,075 | |
Jan 19 2021 | MGEN | Viridian Therapeut ... | Rauch Lee M. | Option Exercise | A | 23.03 | 15,000 | 345,450 | 15,000 | ||
Nov 16 2020 | MGEN | MIRAGEN THERAPEUTI ... | Logos Global Master Fund LP | 10% Owner | Buy | P | 14.84 | 126,667 | 1,879,599 | 550,000 | 423.3 K to 550 K (+29.92 %) |
Nov 16 2020 | MGEN | MIRAGEN THERAPEUTI ... | Logos Global Master Fund LP | 10% Owner | Buy | P | 1.16 | 100,000 | 116,410 | 6,350,000 | 6.3 M to 6.4 M (+1.60 %) |
Nov 16 2020 | MGEN | MIRAGEN THERAPEUTI ... | Logos Global Master Fund LP | 10% Owner | Buy | P | 1.10 | 250,000 | 274,475 | 6,250,000 | 6 M to 6.3 M (+4.17 %) |
Oct 30 2020 | MGEN | MIRAGEN THERAPEUTI ... | Fairmount Funds Management LLC | Director | Option Exercise | P | 0.00 | 28,843 | 0 | 111,192 | |
Oct 30 2020 | MGEN | MIRAGEN THERAPEUTI ... | Fairmount Funds Management LLC | Director | Option Exercise | P | 0.00 | 28,843 | 0 | 111,192 | |
Oct 30 2020 | MGEN | MIRAGEN THERAPEUTI ... | Fairmount Funds Management LLC | Director | Option Exercise | P | 0.00 | 5,494 | 0 | 21,999 | |
Oct 30 2020 | MGEN | MIRAGEN THERAPEUTI ... | Fairmount Funds Management LLC | Director | Option Exercise | P | 0.00 | 5,494 | 0 | 21,999 | |
Oct 29 2020 | MGEN | MIRAGEN THERAPEUTI ... | Harwin Peter Evan | Director | Option Exercise | A | 0.52 | 24,000 | 12,478 | 24,000 | |
Oct 29 2020 | MGEN | MIRAGEN THERAPEUTI ... | Kiselak Tomas | Director | Option Exercise | A | 0.52 | 24,000 | 12,478 | 24,000 | |
Sep 15 2020 | MGEN | MIRAGEN THERAPEUTI ... | Rauch Lee M. | President & CEO | Option Exercise | A | 0.91 | 900,000 | 817,830 | 900,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | TURNER JOSEPH L | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | Morris Arlene | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | KOCH KEVIN | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
Mar 17 2020 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | M | 0.57 | 11,249 | 6,412 | 0 | |
Mar 17 2020 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Buy | M | 0.57 | 11,249 | 6,412 | 48,829 | 37.6 K to 48.8 K (+29.93 %) |
Feb 14 2020 | MGEN | MIRAGEN THERAPEUTI ... | Escolar Diana | Chief Medical Offic ... | Option Exercise | A | 0.80 | 270,000 | 214,650 | 270,000 | |
Feb 14 2020 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | A | 0.80 | 185,000 | 147,075 | 185,000 | |
Feb 14 2020 | MGEN | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | A | 0.80 | 464,000 | 368,880 | 464,000 | |
Aug 23 2019 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | M | 0.57 | 3,093 | 1,763 | 0 | |
Aug 23 2019 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Buy | M | 0.57 | 3,093 | 1,763 | 36,330 | 33.2 K to 36.3 K (+9.31 %) |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | TURNER JOSEPH L | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | Morris Arlene | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | KOCH KEVIN | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
Apr 05 2019 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 2.99 | 10,106 | 30,217 | 10,106 | |
Feb 08 2019 | MGEN | MIRAGEN THERAPEUTI ... | RUBIN PAUL D | EVP, Research & Dev ... | Option Exercise | A | 2.96 | 87,000 | 257,520 | 87,000 | |
Feb 08 2019 | MGEN | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Option Exercise | A | 2.96 | 74,000 | 219,040 | 74,000 | |
Feb 08 2019 | MGEN | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | A | 2.96 | 232,000 | 686,720 | 232,000 | |
Oct 12 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Buy | P | 4.77 | 10,000 | 47,697 | 12,827 | 2.8 K to 12.8 K (+353.73 %) |
Aug 09 2018 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | M | 0.57 | 29,530 | 16,832 | 0 | |
Aug 09 2018 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Buy | M | 0.57 | 29,530 | 16,832 | 30,737 | 1.2 K to 30.7 K (+2,446.56 %) |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | TURNER JOSEPH L | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Morris Arlene | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | KOCH KEVIN | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | TURNER JOSEPH L | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Morris Arlene | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | KOCH KEVIN | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hatfield Jeffrey S. | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Booth Bruce | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
Feb 15 2018 | MGEN | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | M | 0.57 | 115,818 | 66,016 | 0 | |
Feb 15 2018 | MGEN | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Buy | M | 0.57 | 115,818 | 66,016 | 265,646 | 149.8 K to 265.6 K (+77.30 %) |
Feb 13 2018 | MGEN | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Buy | P | 5.50 | 9,090 | 49,995 | 10,540 | 1.5 K to 10.5 K (+626.90 %) |
Feb 02 2018 | MGEN | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | A | 7.50 | 245,000 | 1,837,500 | 245,000 | |
Feb 02 2018 | MGEN | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | A | 7.50 | 75,000 | 562,500 | 75,000 | |
Feb 02 2018 | MGEN | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Option Exercise | A | 7.50 | 80,000 | 600,000 | 80,000 | |
Feb 02 2018 | MGEN | MIRAGEN THERAPEUTI ... | RUBIN PAUL D | EVP, Research & Dev ... | Option Exercise | A | 7.50 | 85,000 | 637,500 | 85,000 | |
Jan 05 2018 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 9.72 | 3,426 | 33,301 | 3,426 | |
Jan 05 2018 | MGEN | MIRAGEN THERAPEUTI ... | Booth Bruce | Director | Option Exercise | A | 9.72 | 10,191 | 99,057 | 10,191 | |
Dec 22 2017 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Sell | S | 8.00 | 12,000 | 96,000 | 2,827 | 14.8 K to 2.8 K (-80.93 %) |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | KOCH KEVIN | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | TURNER JOSEPH L | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | Creecy John W | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | Booth Bruce | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
Jun 23 2017 | MGEN | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Buy | P | 7.55 | 200 | 1,510 | 200 | 0 to 200 |
Mar 28 2017 | MGEN | MIRAGEN THERAPEUTI ... | Booth Bruce | Director | Option Exercise | A | 11.80 | 6,844 | 80,759 | 6,844 | |
Mar 28 2017 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Option Exercise | A | 11.80 | 1,191 | 14,054 | 1,191 | |
Mar 28 2017 | MGEN | MIRAGEN THERAPEUTI ... | Hughes Thomas E. | Director | Grant | A | 0.00 | 778 | 0 | 14,840 | 14.1 K to 14.8 K (+5.53 %) |
Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.31 | 3,300 | 47,229 | 463,473 | 466.8 K to 463.5 K (-0.71 %) |
Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.38 | 2,500 | 35,962 | 466,773 | 469.3 K to 466.8 K (-0.53 %) |
Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.70 | 5,000 | 73,514 | 469,273 | 474.3 K to 469.3 K (-1.05 %) |
Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 16.24 | 608 | 9,874 | 474,273 | 474.9 K to 474.3 K (-0.13 %) |
Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 15.71 | 9,392 | 147,590 | 474,881 | 484.3 K to 474.9 K (-1.94 %) |
Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.54 | 2,258 | 30,580 | 484,273 | 486.5 K to 484.3 K (-0.46 %) |
Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.79 | 1,500 | 20,687 | 486,531 | 488 K to 486.5 K (-0.31 %) |
Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.04 | 6,500 | 91,252 | 488,031 | 494.5 K to 488 K (-1.31 %) |
Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.65 | 1,800 | 24,566 | 494,531 | 496.3 K to 494.5 K (-0.36 %) |
Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.36 | 4,102 | 58,886 | 496,331 | 500.4 K to 496.3 K (-0.82 %) |
Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | A | 11.01 | 77,500 | 853,275 | 77,500 | |
Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | RUBIN PAUL D | EVP, Research & Dev ... | Option Exercise | A | 11.01 | 87,500 | 963,375 | 87,500 | |
Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Option Exercise | A | 11.01 | 87,500 | 963,375 | 87,500 | |
Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | A | 11.01 | 200,000 | 2,202,000 | 200,000 | |
Feb 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEBOW BENNETT S | Director | Buy | M | 5.39 | 279,067 | 1,504,171 | 280,600 | 1.5 K to 280.6 K (+18,203.98 %) |
Feb 08 2017 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
Feb 08 2017 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,899 | 699 to 1.9 K (+171.67 %) |
Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,533 | 333 to 1.5 K (+360.36 %) |
Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,900 | 700 to 1.9 K (+171.43 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | M | 0.00 | 46,000 | 0 | 0 | |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Payment of Exercise | F | 0.36 | 45,580 | 16,409 | 106,447 | 152 K to 106.4 K (-29.98 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Buy | M | 0.00 | 100,000 | 0 | 152,027 | 52 K to 152 K (+192.21 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Payment of Exercise | F | 0.36 | 20,967 | 7,548 | 52,027 | 73 K to 52 K (-28.72 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Buy | M | 0.00 | 46,000 | 0 | 72,994 | 27 K to 73 K (+170.41 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Payment of Exercise | F | 0.36 | 103,160 | 37,138 | 571,370 | 674.5 K to 571.4 K (-15.29 %) |
Nov 02 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Buy | M | 0.00 | 200,000 | 0 | 674,530 | 474.5 K to 674.5 K (+42.15 %) |
Aug 10 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | M | 0.00 | 23,000 | 0 | 46,000 | |
Aug 10 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Payment of Exercise | F | 0.49 | 10,484 | 5,085 | 26,994 | 37.5 K to 27 K (-27.97 %) |
Aug 10 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Buy | M | 0.00 | 23,000 | 0 | 37,478 | 14.5 K to 37.5 K (+158.86 %) |
Jun 30 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Option Exercise | M | 0.00 | 124,251 | 0 | 0 | |
Jun 30 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Payment of Exercise | F | 0.46 | 64,835 | 29,824 | 474,530 | 539.4 K to 474.5 K (-12.02 %) |
Jun 30 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Buy | M | 0.00 | 124,251 | 0 | 539,365 | 415.1 K to 539.4 K (+29.93 %) |
Jun 20 2016 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Option Exercise | A | 0.51 | 18,000 | 9,180 | 18,000 | |
Jun 20 2016 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | A | 0.51 | 18,000 | 9,180 | 18,000 | |
Jun 20 2016 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Option Exercise | A | 0.51 | 18,000 | 9,180 | 18,000 | |
Jun 20 2016 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | A | 0.51 | 18,000 | 9,180 | 18,000 | |
May 19 2016 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
May 19 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Feb 12 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Option Exercise | M | 0.00 | 124,252 | 0 | 124,251 | |
Feb 12 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Payment of Exercise | F | 0.46 | 54,268 | 24,963 | 415,114 | 469.4 K to 415.1 K (-11.56 %) |
Feb 12 2016 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Buy | M | 0.00 | 124,252 | 0 | 469,382 | 345.1 K to 469.4 K (+36.00 %) |
Nov 23 2015 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Buy | P | 0.80 | 7,000 | 5,600 | 345,130 | 338.1 K to 345.1 K (+2.07 %) |
Nov 23 2015 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President & CEO | Buy | P | 0.78 | 7,000 | 5,460 | 338,130 | 331.1 K to 338.1 K (+2.11 %) |
Aug 14 2015 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | A | 1.57 | 60,000 | 94,200 | 60,000 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Option Exercise | A | 1.62 | 18,000 | 29,160 | 18,000 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Option Exercise | M | 0.00 | 4,125 | 0 | 0 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Grant | A | 0.00 | 5,000 | 0 | 10,500 | 5.5 K to 10.5 K (+90.91 %) |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Buy | M | 0.00 | 4,125 | 0 | 5,500 | 1.4 K to 5.5 K (+300.00 %) |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Option Exercise | A | 1.62 | 18,000 | 29,160 | 18,000 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | A | 1.62 | 18,000 | 29,160 | 18,000 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | M | 0.00 | 4,125 | 0 | 0 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Grant | A | 0.00 | 5,000 | 0 | 10,500 | 5.5 K to 10.5 K (+90.91 %) |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Buy | M | 0.00 | 4,125 | 0 | 5,500 | 1.4 K to 5.5 K (+300.00 %) |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | A | 1.62 | 18,000 | 29,160 | 18,000 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 0.00 | 4,125 | 0 | 0 | |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Grant | A | 0.00 | 5,000 | 0 | 10,500 | 5.5 K to 10.5 K (+90.91 %) |
Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 0.00 | 4,125 | 0 | 5,500 | 1.4 K to 5.5 K (+300.00 %) |
Aug 05 2015 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Option Exercise | M | 0.00 | 23,000 | 0 | 69,000 | |
Aug 05 2015 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Payment of Exercise | F | 1.56 | 8,522 | 13,294 | 14,478 | 23 K to 14.5 K (-37.05 %) |
Aug 05 2015 | SGNL | SIGNAL GENETICS, I ... | SEYMOUR TAMARA A | CFO, Secretary, Tre ... | Buy | M | 0.00 | 23,000 | 0 | 23,000 | 0 to 23 K |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 0.00 | 1,375 | 0 | 4,125 | |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 0.00 | 1,375 | 0 | 1,375 | 0 to 1.4 K |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Option Exercise | M | 0.00 | 1,375 | 0 | 4,125 | |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Schuling Douglas A | Director | Buy | M | 0.00 | 1,375 | 0 | 1,375 | 0 to 1.4 K |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | M | 0.00 | 1,375 | 0 | 4,125 | |
Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Buy | M | 0.00 | 1,375 | 0 | 1,375 | 0 to 1.4 K |
Jun 23 2015 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President and CEO | Option Exercise | M | 0.00 | 124,252 | 0 | 248,503 | |
Jun 23 2015 | SGNL | SIGNAL GENETICS, I ... | Riccitelli Samuel D | President and CEO | Payment of Exercise | F | 1.51 | 46,036 | 69,514 | 331,130 | 377.2 K to 331.1 K (-12.21 %) |